BA
The Boeing Company
BA has the edge over HON overall, supported by stronger fundamentals and stronger modeled upside.
HON
Honeywell International Inc.
HON offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
HON Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Healthy | |
| Stable | |
| Healthy |
HON's profitability and balance sheet are currently healthy, and its cash flow is stable, but its revenue is weak.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over HON in the historical PE scenario, which offers more potential upside but is not a forecast.
HON PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $223 | — |
| Cheap | 20x | $438 | +96% |
| Fair | 23x | $515 | +130% |
| Forward | 24x | $223 | — |
| Expensive | 28x | $628 | +181% |
Historical ranges are pointers, not guarantees.
HON's PE is in its cheap range at 10x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 24x, in its fair range.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over HON on the outlook, with more favorable earnings and revenue expectations.
HON Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Strong decline | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect HON's profitability to improve, but its revenue to decline.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
HON Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.49 | -57% |
| Q3 2026 | $22.13 | +17% |
| Q2 2026 | $25.77 | +47% |
| Q1 2026 | $12.84 | -26% |
| Q4 2025 | $14.70 | -16% |
| Q3 2025 | $18.98 | +9.6% |
| Q2 2025 | $17.58 | +0.2% |
| Q1 2025 | $17.40 | +0.8% |
| Q4 2024 | $17.42 | +2.8% |
HON has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over HON on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
HON Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5B | -52% |
| Q2 2026 | $9.7B | -6.1% |
| Q1 2026 | $9.1B | -6.9% |
| Q4 2025 | $9.8B | -3.3% |
| Q3 2025 | $10.4B | +7% |
| Q2 2025 | $10.4B | +8.1% |
| Q1 2025 | $9.8B | +7.9% |
| Q4 2024 | $10.1B | +6.9% |
HON's revenue has slid since its 2025 peak: $5B last quarter, down 52% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 21% | -1.9 points |
| Q2 2026 | 23% | +0.2 points |
| Q1 2026 | 23% | +0.3 points |
| Q4 2025 | 11% | -9.7 points |
| Q3 2025 | 23% | -0.5 points |
| Q2 2025 | 23% | -0.1 points |
| Q1 2025 | 23% | +0.8 points |
| Q4 2024 | 21% | +5 points |
HON has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over HON on cash flow, with more consistent year-over-year improvement.
HON Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $286M | -90% |
| Q2 2026 | $961M | -5.4% |
| Q1 2026 | -$873M | -352% |
| Q4 2025 | $1.1B | -39% |
| Q3 2025 | $2.9B | +70% |
| Q2 2025 | $1B | -8.6% |
| Q1 2025 | $346M | +61% |
| Q4 2024 | $1.9B | -27% |
HON still generates free cash flow, though less than at its 2025 peak: $1.5B over the past year.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
HON Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +600K shares |
| 1 year | -0.1% | -200K shares |
| 3 years | -4.3% | -14.3M shares |
| 5 years | -8.7% | -30.3M shares |
| Available history | -13% | -46M shares |
HON has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $1B |
| Q4 2025 | $100M |
| Q3 2025 | $100M |
| Q2 2025 | $1.7B |
| Q1 2025 | $1.9B |
| Q4 2024 | $455M |
HON spent $1.1B buying back its own shares over the past year, down 74% from the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
HON Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.4x | Healthy |
| Q2 2026 | 2.8x | Moderate |
| Q1 2026 | 2.6x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 2.3x | Moderate |
| Q2 2025 | 2.5x | Moderate |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
HON has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
HON Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.9 | Neutral |
| Stochastic | 45.0 | Neutral |
HON's weekly RSI is 52 (neutral) and its Stochastic is 45 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
HON PE vs Industrials Sector
| Metric | HON | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 24x | 58% below |
| PE % | 4 | 58 | 54 pts below |
HON has the edge over BA on valuation relative to its sector.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
HON Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $216.1 | 3.4% above |
| 20 week MA | $221.4 | 0.9% above |
| 50 week MA | $223.8 | 0.1% below |
| 100 week MA | $215.2 | 3.9% above |
| 200 week MA | $203.7 | 9.7% above |
HON has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
HON Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $169.2 | $200.8 | +19% |
| 2021 | $200.8 | $196.7 | -2.1% |
| 2022 | $196.7 | $205.0 | +4.2% |
| 2023 | $205.0 | $201.0 | -1.9% |
| 2024 | $201.0 | $220.0 | +9.4% |
| 2025 | $220.0 | $200.7 | -8.8% |
| 2026 YTD | $200.7 | $223.5 | +11% |
HON has the edge over BA on returns for 2026, with the stronger performance.